Amino acid · Fact sheet

Glycine

Glycine is an amino acid with small human studies of sleep and next-day fatigue. These early results do not establish treatment of chronic insomnia or the benefits of glycine alone for healthy aging.

Not FDA approvedEarly human evidence

What is Glycine?

Glycine is a building block for proteins and glutathione and also participates in nervous-system signaling. Being naturally present in the body does not settle the benefits or risks of supplementation.

Benefits & claims

Better sleep, reduced next-day fatigue, collagen support, and healthy aging drive interest. Studies combining glycine with N-acetylcysteine cannot isolate glycine’s contribution.

What the evidence supports

  • Small studies reported improved subjective sleep or reduced next-day fatigue in selected conditions.
  • These results do not establish a treatment for chronic insomnia or prove an anti-aging benefit.
Research areas
  • Sleep quality
  • Daytime fatigue after sleep restriction
  • Glutathione-related metabolism

Dosage & frequency

Human study context

A small sleep-restriction experiment provides an oral study amount. It is not a validated long-term insomnia treatment schedule.

How to read these amounts

An approved regimen belongs to a specific product, indication, and population. A study regimen describes what researchers tested; it does not establish a prescription or a safe self-use protocol. Products, routes, and formulations are not interchangeable. A prescriber uses the full label and individual clinical circumstances.

Personal accounts may describe amounts, schedules and outcomes beyond clinical research. They do not establish a regimen. Read the reported experiences

Formulations, interactions & practical context

Formulation differences

  • The study examined glycine alone, not a GlyNAC combination.

Interactions & precautions

  • The small sleep study does not establish a comprehensive interaction profile with sleep medicines or other CNS-active substances.

What is still unresolved

  • Long-term effects in clinical insomnia and different sleep disorders remain uncertain.

Side effects & risks

  • The short sleep studies cannot establish uncommon adverse effects or long-term safety.
  • Safety and effects of multi-ingredient products cannot be inferred from isolated-glycine studies.

This is a summary of the cited evidence, not a complete product label. A lack of human safety data does not establish safety.

Clinical research

Early human evidence

The sleep literature cited here uses small, short experiments, including sleep restriction. Findings on subjective fatigue or a laboratory sleep night need confirmation in larger clinical populations.

Studies

Personal experiences

Reports describe what someone noticed. They cannot establish cause, typical results, or how often a side effect happens. Amounts and schedules describe the individual account, not an effective or safe dose. Product identity and strength may be unverified, and missing details are left explicit.

Explore 4 sourced accounts by reported effect.

Energy: reported experiences

Negative account · personal report

Earlier waking and afternoon tiredness

Another person described shorter sleep and afternoon fatigue after starting glycine, then more usual sleep on a day without it.

Reported use in this account

Product
Product described as glycine
Amount
3 grams
Frequency
Not specified clearly
Route
Not specified clearly
Duration
About three days

Other exposures described: Vimpat and low-dose escitalopram

The poster also described irregular sleep, epilepsy and prescription medicines. These confounders prevent a confident causal conclusion.

Read the contrasting sleep account

Approval status

Glycine has no FDA-approved drug indication for the wellness uses discussed here. Supplement availability is not premarket FDA approval of effectiveness or safety.

Supplement research is not FDA drug approval

Approval covers the labeled product, use and population. A trial phase does not establish success; a stopped program is not ongoing research.

Open questions

  • Durable improvement in diagnosed sleep disorders
  • Long-term outcomes from glycine alone
  • Effects in different age groups and with other medicines

Summary

These results do not establish a treatment for chronic insomnia or prove an anti-aging benefit.

Sources

Medical evidence and regulatory sources are listed here. Personal reports are linked separately in the experiences section.

  1. pubmedGlycine and daytime performance after sleep restriction

    Small short-term human experiment; animal circadian experiments reported separately.

  2. journalGlycine and subjective and polysomnographic sleep measures

    Small human sleep study published in Sleep and Biological Rhythms.

  3. fdaFDA: what approval means for supplements

    Dietary supplements are not approved by FDA for safety and effectiveness before marketing.

  4. journalOriginal glycine sleep-restriction experiment: full text

    Bannai et al., 2012; same study as PMID22529837, with three-night 3 g exposure in healthy volunteers.

How we assess sources · Suggest a correction